The trend was seen across all the racial and ethnic groups studied and could provide insight into improving vaccination rates for COVID-19 and other illnesses.
Research brief: A UCLA team has demonstrated that altering a key molecule used in the therapy yields superior and longer-lasting results in mouse models.
Both vaccinated and non-vaccinated personnel will be tested to gauge how well the vaccines prevent infections and lessen their impact when they do occur.
The study, conducted in mice, opens a path for exploring treatments that combine epigenetic approaches with therapies that use the body’s natural immune response.